[HTML][HTML] Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis
X Liu, Y Lang, Q Chai, Y Lin, Y Liao… - Frontiers in Pharmacology, 2022 - frontiersin.org
Purpose: According to the IMvigor130 trial, adding atezolizumab to platinum-based
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …
Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis
X Liu, Y Lang, Q Chai, Y Lin, Y Liao, Y Zhu - 2022 - repository.um.edu.mo
Purpose: According to the IMvigor130 trial, adding atezolizumab to platinum-based
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …
Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis.
X Liu, Y Lang, Q Chai, Y Lin, Y Liao… - Frontiers in …, 2022 - europepmc.org
Purpose: According to the IMvigor130 trial, adding atezolizumab to platinum-based
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …
Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis
X Liu, Y Lang, Q Chai, Y Lin, Y Liao… - … policy, impact and …, 2023 - books.google.com
Purpose: According to the IMvigor130 trial, adding atezolizumab to platinumbased
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …
Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis
X Liu, Y Lang, Q Chai, Y Lin… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose: According to the IMvigor130 trial, adding atezolizumab to platinum-based
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …
[HTML][HTML] Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis
X Liu, Y Lang, Q Chai, Y Lin, Y Liao… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Purpose: According to the IMvigor130 trial, adding atezolizumab to platinum-based
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …
Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis.
X Liu, Y Lang, Q Chai, Y Lin, Y Liao… - Frontiers in …, 2022 - europepmc.org
Purpose: According to the IMvigor130 trial, adding atezolizumab to platinum-based
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …